The use of brachytherapy to treat renal artery in-stent restenosis

Journal of Interventional Cardiology

Volumn 18, Issue 1, 2005, Pages 49-54

  Ellis, Keith ^a   Murtagh, Blaithnead ^a   Loghin, Catalin ^a   Muench, Andreas ^a   Boccalandro, Fernando ^a   Go, Brian ^a   Ahmad, Muhammad ^a   Burjonroppa, Sukesh ^a   Rosales, Oscar ^a   Smalling, Richard W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; CLOPIDOGREL; HYDROCHLOROTHIAZIDE; LANSOPRAZOLE; LEVOTHYROXINE; METOPROLOL; STRONTIUM 90;

ADULT; AGED; ARTICLE; BETA RADIATION; BRACHYTHERAPY; CASE REPORT; CATHETER; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; KIDNEY ARTERY STENOSIS; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT; TREATMENT OUTCOME;

AGED; BRACHYTHERAPY; FEMALE; HUMANS; MIDDLE AGED; RECURRENCE; RENAL ARTERY OBSTRUCTION; STENTS;

EID: 20144386720     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.04043.x     Document Type: Article

References (14)

1. Plouin RA, Baldauf CG, Millward SF, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823-829.
2. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329-335.
3. Van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease. A randomized trial. Lancet 1999;353:282-286.
4. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: Utility in difficult lesions for balloon angioplasty. J Am Coll Cardiol 1997;30:1445-1450.
5. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: Characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314-323.
6. Tan WA, Yadav JS, Wholey MH, et al. Endovascular options for peripheral arterial occlusive and aneurysmal disease. In: Topol EJ, ed. Textbook of Interventional Cardiology 4th edn. Philadelphia: WB Saunders, 2003:481-522.
7. Olin JW, Begelman SM. Renal artery disease. In: Topol EJ, ed. Textbook of Cardiovascular Medicine 2nd edn. Philadelphia: Lippincott Williams and Wilkins, 2002:2139-2159.
8. Safian RD, Textor SC. Renal artery stenosis. N Engl J Med 2001;344:431-442.
9. Williams DO. Intracoronary brachytherapy: Past, present, and future. Circulation 2002;105:2699-2700.
10. Aslam MS, Balasubramanian J, Greenspahn BR. Brachytherapy for renal artery in-stent restenosis. Cathet Cardiovasc Intervent 2003;58:151-154.
11. Chrysant GS, Goldstein JA, Casserly IP, et al. Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis. Cathet Cardiovasc Intervent 2003;59:251-254.
12. Stoeteknuel-Friedli S, Do DD, von Briel C, et al. Endovascular brachytherapy for prevention of recurrent renal in-stent restenosis. J Endovasc Ther 2002;9:350-353.
13. Munneke GJ, Engelke C, Moorgan RA, et al. Cutting balloon angioplasty for resistant renal artery in-stent restenosis. J Vasc Interv Radiol 2002;13:327-331.
14. Summary of Safety and Effectiveness Data: The Novoste Beta Cath. Norcross, GA: Novoste (see http://www.fda.gov/cdrh/pma/pmanov00.html).